VistaGen Reports Phase 2 Results for AV-101
15 Nov 2019 //
PR NEWSWIRE
Relmada Therapeutics to Announce Results of Phase 2 Study of REL-1017
14 Oct 2019 //
PRNEWSWIRE
Inhaled or injected general anaesthetic agents and sedative medicines
02 Oct 2018 //
TGA
How Ketamine could cure depression
30 Jan 2017 //
DRUG TARGET REVIEW